• Cambridge Biotech Wants Workers To Understand Patients' Diet Experience

    Dec 6, 2017, 11:26 AM by Michael Croft
    The Boston Globe | Biotech companies developing drugs for rare diseases often invite patients to visit so workers can put a human face on illnesses that could be viewed as abstract scientific puzzles. Akcea Therapeutics is taking that idea further - it wants staffers to get a taste of life with a super-rare metabolic disorder.
    Full story

  • TraceLink Unveils FutureLink

    Dec 6, 2017, 10:31 AM by Michael Croft
    NORTH READING, MA, US - Dec 6, 2017 - North Reading, MA —TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today unveiled FutureLink—a new annual gathering of commercial and operational executives from the pharmaceutical and healthcare industries who are dedicated to achieving regulatory compliance and shaping the future of digital drug supply with information sharing networks
    Full story

  • Celmatix Names Lori Batta as Chief Commercial Officer

    Dec 6, 2017, 09:32 AM by Michael Croft
    NEW YORK, NY, UNITED STATES - Dec 6, 2017 - Today, Celmatix, a next-generation women’s health company, announced that Lori Batta, a seasoned healthcare executive with more than 25 years of experience, has been promoted to the role of Chief Commercial Officer (CCO)
    Full story

  • Google Has Released An AI Tool That Makes Sense Of Your Genome

    Dec 5, 2017, 14:25 PM by Michael Croft
    MIT Technology Review | AI tools could help us turn information gleaned from genetic sequencing into life-saving therapies.
    Full story

  • Medherant, EightSpokes, Cambridge Semantics, And More: News From November 2017

    Dec 5, 2017, 12:05 PM by Michael Croft

    Bio-IT World | November featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Medherant, EightSpokes, Cambridge Semantics, and more.

    Full story

  • Oxford Genetics announces adeno-associated virus collaboration with MeiraGTx

    Dec 5, 2017, 07:05 AM by Michael Croft
    OXFORD, UK - Dec 5, 2017 - 5 December 2017, Oxford -  Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has established a new agreement with clinical-stage gene therapy company, MeiraGTx
    Full story

  • NVIDIA Extends GPU Cloud Support For AI Researchers

    Dec 4, 2017, 14:55 PM by Michael Croft
    Bio-IT World Brief  NVIDIA has extended NVIDIA GPU Cloud (NGC) support to NVIDIA TITAN, giving AI researchers using desktop GPUs access to NGC. The company has also added new software and other key updates to the NGC container registry to provide researchers a broader, more powerful set of tools to advance their AI and high performance computing research and development efforts.
    Full story

  • Deep Learning In The Clinic: Predicting Patient Prognosis

    Dec 4, 2017, 13:20 PM by Michael Croft
    Bio-IT World | In a paper published last month on arXiv, and not yet peer-reviewed, Stanford researchers outlined how machine learning can be made to predict prognosis in a clinical setting.
    Full story

  • Certara Launches Version 17 of its PBPK Simcyp Simulator

    Dec 4, 2017, 09:33 AM by Michael Croft
    PRINCETON, NJ - Dec 4, 2017 - Certara®, the global leader in model-informed drug development and regulatory science, today announced that it has launched version 17 of its Simcyp® Population-based Simulator
    Full story

  • Edico Genome Launches DRAGEN Complete Suite On AWS Marketplace

    Dec 1, 2017, 09:40 AM by Michael Croft

    Bio-IT World Brief | During the AWS re:Invent, Edico Genome revealed its DRAGEN Complete Suite on AWS Marketplace, a comprehensive package of pipelines that enables AWS users to access all of DRAGEN's applications for next-generation sequencing data analysis in one click.

    Full story

  • Bioclinica Launches Clinical Adjudication Led by Experienced Medical Specialists and Researchers for Enhanced Safety and Efficacy in Clinical Trials

    Nov 30, 2017, 15:09 PM by Michael Croft
    DOYLESTOWN, PA, UNITED STATES - Nov 30, 2017 - Bioclinica®, the world-leading provider of technology-enabled solutions for clinical research, today announces the launch of Bioclinica Clinical Adjudication, a transformational offering in which medical specialists and researchers, backed by advanced technology, lead independent Clinical Event Committee (CEC) review
    Full story

  • Bioclinica Appoints David Herron as Chief Executive Officer

    Nov 30, 2017, 15:04 PM by Michael Croft
    DOYLESTOWN, PA, UNITED STATES - Nov 29, 2017 - Bioclinica®, a world-leading provider of specialty clinical trial services, has appointed David Herron as the company’s next Chief Executive Officer, effective January 2, 2018
    Full story

  • MDI Biological Laboratory Scientist Receives Grant to Study Aging

    Nov 30, 2017, 13:41 PM by Michael Croft
    BAR HARBOR, ME - Nov 30, 2017 - The MDI Biological Laboratory has announced that Aric Rogers, Ph.D., has received a grant of $455,000 over two years from the National Institute on Aging (NIA), one of the institutes of the National Institutes of Health, for research on the cellular mechanisms governing longevity
    Full story

  • AWS Adds Capabilities For Amazon Aurora And Amazon DynamoDB, Introduces Amazon Neptune

    Nov 30, 2017, 13:35 PM by Michael Croft

    Bio-IT World Brief | Yesterday at AWS re:Invent, Amazon Web Services (AWS) announced new database capabilities for Amazon Aurora and Amazon DynamoDB, and introduced Amazon Neptune, a new fully managed graph database service.

    Full story

  • Creative Biolabs Launched Comprehensive ADC in vitro Analysis Service

    Nov 30, 2017, 04:02 AM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Nov 30, 2017 - Recently, Creative Biolabs, a professional antibody company with years of experience, has launched a brand new ADC in vitro analysis service, aiming to provide a guideline for ADC optimization and the downstream in vivo ADC assessment and a high-quality one-stop service for their clients around the world
    Full story

  • SAP Information Collaboration Hub for Life Sciences Helps Safeguard Patient Health

    Nov 29, 2017, 12:13 PM by Michael Croft
    WALLDORF, GERMANY - Nov 29, 2017 - SAP SE (NYSE: SAP) today announced the launch of SAP Information Collaboration Hub for Life Sciences, a public cloud network that makes collaboration easier for pharmaceutical supply chain trading partners
    Full story

  • A Virus Shortage? BlueBird Bio Buys A Factory To Make Its Own

    Nov 29, 2017, 11:14 AM by Michael Croft
    Forbes | Amid a reported shortage of the disabled viruses used for gene therapies, BlueBird Bio has purchased a 125,000-square-foot facility in Durham, North Carolina, that it will use for manufacturing the lentiviral vectors used in its treatments.
    Full story

  • AI Exposes Patterns For Faster Drug Discovery

    Nov 29, 2017, 09:20 AM by Michael Croft

    Bio-IT World Contributed Commentary | Though the results are just starting to emerge, AI is showing positive traction in drug development. Machine learning in particular can help pharma recover the value of repurposed drugs by finding new therapeutic applications for them.

    Full story

  • Tjoapack launches new bottle packing line

    Nov 29, 2017, 05:48 AM by Michael Croft
    ETTEN-LEUR, NETHERLANDS - Nov 29, 2017 - Contract packaging organisation (CPO), Tjoapack, has launched its new bottle packing line following a major investment earlier this year
    Full story

  • Tissue Science and Regenerative Medicine

    Nov 29, 2017, 05:44 AM by Michael Croft
    SYDNEY, AUSTRALIA - Jul 13, 2018 - 9th International Conference on Tissue Science and Regenerative Medicine is mainly based on the theme “Exploring the frontiers in tissue science and Medicine’’ We warmly welcome all the participants of world’s leading Scientists, Researchers and Scholars
    Full story